TrialBMC cancer2011

A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma.

Thomas Schmitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.